Akash Deep

Akash Deep

Auto-generated profile, based on publicly available information

Akash Deep

Paediatric Intensive Care Unit, King’s College Hospital NHS Foundation Trust, London, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2013 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
ADAkash Deep
Akash Deep
CGChulananda D. A. Goonasekera
Chulananda D. A. Goonasekera
YWYanzhong Wang
Yanzhong Wang
JBJoe Brierley
Joe Brierley

1 December 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
MDMarco Daverio
Marco Daverio
GCGerard Cortina
Gerard Cortina
AJAndrew Jones
Andrew Jones
ZRZaccaria Ricci
Zaccaria Ricci
DDDemet Demirkol
Demet Demirkol
FNFelix Neunhoeffer
Felix Neunhoeffer
Continuous kidney replacement therapy (CKRT) is the preferred method of kidney support in the pediatric intensive care unit (PICU) because it allows for slow fluid removal and solute normalization in children with hemodynamic instability.1-4 Continuous kidney replacement therapy is increasingly being used in the PICU both for kidney and nonkidney indications (acute kidney injury [AKI], fluid overload [FO], electrolyte instability, acid-base imbalances, sepsis [for removal of inflammatory mediators], acute liver failure, inborn errors of metabolism, or drug/toxin removal).5-10 However, due to the lack of evidence and standardized, practice-based recommendations, wide variations in practice exist in all aspects of delivery of CKRT in children with critical illness.11-16 Most protocols for CKRT are therefore based on institutional, personal, or historical experience. Although a limited number of pediatric studies2,3,5-9 have described the demographic characteristics and outcome data of children with critical illness requiring CKRT, detailed information on current practices for the management of pediatric CKRT in Europe is lacking.

17 November 2023 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
GCGerard Cortina
Gerard Cortina
MDMarco Daverio
Marco Daverio
DDDemet Demirkol
Demet Demirkol
RCRahul Chanchlani
Rahul Chanchlani
ADAkash Deep
Akash Deep
Continuous renal replacement therapy (CRRT) is the preferred method for renal support in critically ill and hemodynamically unstable children in the pediatric intensive care unit (PICU) as it allows for gentle removal of fluids and solutes. The most frequent indications for CRRT include acute kidney injury (AKI) and fluid overload (FO) as well as non-renal indications such as removal of toxic metabolites in acute liver failure, inborn errors of metabolism, and intoxications and removal of inflammatory mediators in sepsis. AKI and/or FO are common in critically ill children and their presence is associated with worse outcomes. Therefore, early recognition of AKI and FO is important and timely transfer of patients who might require CRRT to a center with institutional expertise should be considered. Although CRRT has been increasingly used in the critical care setting, due to the lack of standardized recommendations, wide practice variations exist regarding the main aspects of CRRT application in critically ill children. Conclusion: In this review, from the Critical Care Nephrology section of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC), we summarize the key aspects of CRRT delivery and highlight the importance of adequate follow up among AKI survivors which might be of relevance for the general pediatric community. What is Known:• CRRT is the preferred method of renal support in critically ill and hemodynamically unstable children in the PICU as it allows for gentle removal of fluids and solutes.• Although CRRT has become an important and integral part of modern pediatric critical care, wide practice variations exist in all aspects of CRRT. What is New:• Given the lack of literature on guidance for a general pediatrician on when to refer a child for CRRT, we recommend timely transfer to a center with institutional expertise in CRRT, as both worsening AKI and FO have been associated with increased mortality.• Adequate follow-up of PICU patients with AKI and CRRT is highlighted as recent findings demonstrate that these children are at increased risk for adverse long-term outcomes.

1 March 2018 in Pediatric Nephrology
Verified
Journal Article
Open access
PDF file
ADAkash Deep
Akash Deep
RSRomit Saxena
Romit Saxena
BJBipin Jose
Bipin Jose
Acute kidney injury (AKI) is a common accompaniment in patients with liver disease. The causes, risk factors, manifestations and management of AKI in these patients vary according to the liver disease in question (acute liver failure, acute-on-chronic liver failure, post-liver transplantation or metabolic liver disease). There are multiple causes of AKI in patients with liver disease—pre-renal, acute tubular necrosis, post-renal, drug-induced renal failure and hepatorenal syndrome (HRS). Definitions of AKI in liver failure are periodically revised and updated, but pediatric definitions have still to see the light of the day. As our understanding of the pathophysiology of liver disease and renal involvement improves, treatment modalities have become more advanced and rationalized. Treatment includes reversing precipitating factors, such as infections and gastrointestinal bleeding, volume expansion, paracentesis and vasoconstrictors. This approach is tried and tested in adults. A pediatric tailored approach is still lacking due to inadequate numbers of patients, differences in causes of AKI and paucity of literature. In this review, we attempt to explore the pathophysiological basis, treatment modalities and controversies in the diagnosis and treatment of AKI in pediatric patients with chronic liver disease and discuss our own personal practice. We recognize that, although it is not a very commonly encountered entity in pediatric population, HRS has specific diagnostic criteria and treatment modalities that differ from other causes of AKI in patients with chronic liver disease; hence among the etiologies of kidney injury in patients with chronic liver disease, we focus here on HRS.

12 October 2020 in Critical Care Medicine
Verified
Journal Article
Closed access
ADAkash Frcpch Deep
Akash Frcpch Deep
GUGaurang Mrcpch Upadhyay
Gaurang Mrcpch Upadhyay
PPPascale Mrcpch du Pré
Pascale Mrcpch du Pré
JLJon Mrcpch Lillie
Jon Mrcpch Lillie
DPDaniel Mrcp Pan
Daniel Mrcp Pan
PRPadmanabhan Ramnarayan
Padmanabhan Ramnarayan
Objectives: To study the prevalence, evolution, and clinical factors associated with acute kidney injury in children admitted to PICUs with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2. Design: Multicenter observational study. Setting: Fifteen PICUs across the United Kingdom. Patients: Patients admitted to United Kingdom PICUs with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2 between March 14, 2020, and May 20, 2020. Interventions: None. Measurements and Main Results: Deidentified data collected as part of routine clinical care were analyzed. All children were diagnosed and staged for acute kidney injury based on the level of serum creatinine above the upper limit of reference interval values according to published guidance. Severe acute kidney injury was defined as stage 2/3 acute kidney injury. Uni- and multivariable analyses were performed to study the association between demographic data, clinical features, markers of inflammation and cardiac injury, and severe acute kidney injury. Over the study period, 116 patients with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2 were admitted to 15 United Kingdom PICUs. Any-stage acute kidney injury occurred in 48 of 116 patients (41.4%) and severe acute kidney injury in 32 of 116 (27.6%) patients, which was mostly evident at admission (24/32, 75%). In univariable analysis, body mass index, hyperferritinemia, high C-reactive protein, Pediatric Index of Mortality 3 score, vasoactive medication, and invasive mechanical ventilation were associated with severe acute kidney injury. In multivariable logistic regression, hyperferritinemia was associated with severe acute kidney injury (compared with nonsevere acute kidney injury; adjusted odds ratio 1.04; 95% CI, 1.01–1.08; p = 0.04). Severe acute kidney injury was associated with longer PICU stay (median 5 days [interquartile range, 4–7 d] vs 3 days [interquartile range, 1.5–5 d]; p < 0.001) and increased duration of invasive mechanical ventilation (median 4 days [interquartile range, 2–6 d] vs 2 days [interquartile range, 1–3 d]; p = 0.04). Conclusions: Severe acute kidney injury occurred in just over a quarter of children admitted to United Kingdom PICUs with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2. Hyperferritinemia was significantly associated with severe acute kidney injury. Severe acute kidney injury was associated with increased duration of stay and ventilation. Although short-term outcomes for acute kidney injury in pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2 appear good, long-term outcomes are unknown.

18 October 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
EAEmma C. Alexander
Emma C. Alexander
ADAkash Deep
Akash Deep
After an unexpected cluster of pediatric cases of hepatitis of unknown etiology was identified in Scotland in March 2022,1 the World Health Organization (WHO) announced an outbreak alert. Since then, a review covering October 1, 2021, to July 18, 2022, identified at least 1010 probable cases of acute hepatitis of unknown etiology from 35 countries, including 334 from the US and 272 from the UK.2 Among these probable cases, many of the individuals have experienced progression to acute liver failure (ALF), 46 (4.6%) have required liver transplants, and 22 (2.2%) have died.